Japan Animal Referral Medical Center Co., Ltd. (TYO:6039)

Market Cap	16.83B +180.9%
Revenue (ttm)	6.00B +17.6%
Net Income	787.05M +49.7%
EPS	60.90 +52.6%
Shares Out	12.92M
PE Ratio	21.38
Forward PE	17.26
Dividend	8.00 (0.61%)
Ex-Dividend Date	Mar 30, 2026

Volume	96,700
Average Volume	225,830
Open	1,281.00
Previous Close	1,302.00
Day's Range	1,270.00 - 1,315.00
52-Week Range	420.20 - 1,499.00
Beta	0.46
RSI	47.64
Earnings Date	Feb 16, 2026

About TYO:6039

Japan Animal Referral Medical Center Co., Ltd., together with its subsidiaries, owns and operates animal hospitals that provide advanced medical treatment for dogs and cats in Japan. The company’s medical centers consist of cardiology, respiratory, urology, gastroenterology, oncology, neurology, orthopedics, ophthalmology, radiology and imaging, and anesthesiology departments. It also provides professional training services for veterinarian training and education for advanced medical treatments; and conducts research and development projects, i...

• Industry: Personal Products & Services
• Sector: Consumer Discretionary
• Founded: 2005
• Employees: 294
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6039

Financial Performance

In fiscal year 2025, TYO:6039's revenue was 5.28 billion, an increase of 23.58% compared to the previous year's 4.27 billion. Earnings were 520.00 million, an increase of 54.30%.